2-(1,3-Dioxoisoindolin-2-yl)-N-(2,2,2-trifluoroethyl)acetamide, 98%, 5g

4-BROMO-3-FLUORO-1H-PYRAZOLE, 95.0%, 100mg

{1-[(tert-butoxy)carbonyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}boronic acid, 95.0%, 250mg

6,6'-Dimethyl 5,5'-dibromo-2H,2'H,3H,3'H-[1,1'-biindole]-6,6'-dicarboxylate, 97%, 500mg

3,5-Dihydroxy-6-methyl-2h-pyran-4(3h)-one, 95%, 1g

2-Bromo-1,3,5-tricyclohexylbenzene, 97%, 25g

Nicotinic acid, 95.0%, 500g

N-(4-ethylphenyl)-4-methylbenzenesulfonamide, 95%, 100mg

Calcium carbonate, min. 98.5%, powder, 1 kg, plastic packaging.

2-Chloroaniline, >=98%, for synthesis, 1 L, glass packaging

(S)-4-Bromo-2-((tert-butoxycarbonyl)amino)pent-4-enoic acid, 95.0%, 100mg

Methyl 2-oxo-2,3-dihydro-1H-pyrrolo[3,2-b]pyridine-5-carboxylate, 95.0%, 5g

1-(tert-Butyl) 5-methyl 3-iodo-1H-indazole-1,5-dicarboxylate, 97%, 250mg